Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

20021,232 citationsJournal Article

Authors

Nicole Casadevall · Inserm

J Nataf · Hôtel-Dieu de Paris

B Viron · Hôpital Bichat-Claude-Bernard

Amir Kolta · Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise

Jean‐Jacques Kiladjian · Hôpital Beaujon

P Martin-Dupont

Patrick A. Michaud · Institution de Lavigny

Abstract

Neutralizing antierythropoietin antibodies and pure red-cell aplasia can develop in patients with the anemia of chronic renal failure during treatment with epoetin.

Topics & Keywords

Erythropoietin and Anemia Treatment Blood groups and transfusion Biosimilars and Bioanalytical Methods

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 346, Issue 7, pp. 469-475

DOI: 10.1056/nejmoa011931

Field-Weighted Citation Impact: 41.35